The potential link between microglia activation and CDLBP and nociceptive neurite ingrowth was further investigated in a modified disc punctureinduced degenerationrelated back pain mouse model, using transgenic CX3CR1 GFP/+ mice to fluorescently label microglia in the lumbar spinal cord
Clinical trials including the STEP program demonstrated weight loss at all semaglutide doses above placebo, with greater loss at higher doses
Our quick-access supplements are designed to complement your efforts
Zepbound is the latest diabetes drug approved for weight loss, joining Novo Nordisks Wegovy, a high-dose version of its diabetes treatment Ozempic
As a GLP-1, GIP, and glucagon tri-agonist, its being studied for its complex interactions with metabolic signaling pathways making it a compelling subject for researchers exploring weight management, energy regulation, and hormonal response